These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21813451)

  • 1. TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway.
    Oh JZ; Kurche JS; Burchill MA; Kedl RM
    Blood; 2011 Sep; 118(11):3028-38. PubMed ID: 21813451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.
    Roh YS; Park S; Kim JW; Lim CW; Seki E; Kim B
    Hepatology; 2014 Jul; 60(1):237-49. PubMed ID: 24375615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets.
    Kastenmüller K; Wille-Reece U; Lindsay RW; Trager LR; Darrah PA; Flynn BJ; Becker MR; Udey MC; Clausen BE; Igyarto BZ; Kaplan DH; Kastenmüller W; Germain RN; Seder RA
    J Clin Invest; 2011 May; 121(5):1782-96. PubMed ID: 21540549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
    Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
    Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells.
    Cerovic V; Houston SA; Westlund J; Utriainen L; Davison ES; Scott CL; Bain CC; Joeris T; Agace WW; Kroczek RA; Mowat AM; Yrlid U; Milling SW
    Mucosal Immunol; 2015 Jan; 8(1):38-48. PubMed ID: 24850430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity.
    Oh JZ; Kedl RM
    J Immunol; 2010 Oct; 185(8):4602-8. PubMed ID: 20844205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine analogue AAL-R increases TLR7-mediated dendritic cell responses via p38 and type I IFN signaling pathways.
    Seo YJ; Pritzl CJ; Vijayan M; Blake CR; McClain ME; Hahm B
    J Immunol; 2012 May; 188(10):4759-68. PubMed ID: 22490865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I IFN-induced, NKT cell-mediated negative control of CD8 T cell priming by dendritic cells.
    Bochtler P; Kröger A; Schirmbeck R; Reimann J
    J Immunol; 2008 Aug; 181(3):1633-43. PubMed ID: 18641299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells.
    Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
    J Leukoc Biol; 2010 Jan; 87(1):117-25. PubMed ID: 19843574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists.
    Rajagopal D; Paturel C; Morel Y; Uematsu S; Akira S; Diebold SS
    Blood; 2010 Mar; 115(10):1949-57. PubMed ID: 20065291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
    Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
    J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-β signaling.
    Bourgeois C; Majer O; Frohner IE; Lesiak-Markowicz I; Hildering KS; Glaser W; Stockinger S; Decker T; Akira S; Müller M; Kuchler K
    J Immunol; 2011 Mar; 186(5):3104-12. PubMed ID: 21282509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways.
    Xie G; Welte T; Wang J; Whiteman MC; Wicker JA; Saxena V; Cong Y; Barrett AD; Wang T
    Vaccine; 2013 Aug; 31(38):4143-51. PubMed ID: 23845800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
    Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
    J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: Type I IFN drives emergency myelopoiesis and peripheral myeloid expansion during chronic TLR7 signaling.
    Buechler MB; Teal TH; Elkon KB; Hamerman JA
    J Immunol; 2013 Feb; 190(3):886-91. PubMed ID: 23303674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures.
    Naik SH; Proietto AI; Wilson NS; Dakic A; Schnorrer P; Fuchsberger M; Lahoud MH; O'Keeffe M; Shao QX; Chen WF; Villadangos JA; Shortman K; Wu L
    J Immunol; 2005 Jun; 174(11):6592-7. PubMed ID: 15905497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming.
    Osmond TL; Farrand KJ; Painter GF; Ruedl C; Petersen TR; Hermans IF
    J Immunol; 2015 Aug; 195(3):821-31. PubMed ID: 26078270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.